Urdu Version Of Nottingham Extended Activities Of Daily Living Scale: Reliability And Validity Study

May 6, 2024 updated by: Riphah International University

Is Nottingham Extended Activities Of Daily Living Scale in Urdu Language a Reliable and Valid Tool to Assess the Level of Independence While Performing Activities of Daily Livings

The aim of the study is to know the validity and reliability as well as to translate and culturally adapt the Nottingham Extended Activities Of Daily Living Scale into Urdu language in Pakistani population of Stroke. This study also aims to correlate the scale with the Modified Barthel Index and Frenchay Activities Index.

Study Overview

Status

Completed

Conditions

Detailed Description

As per previous recommendation the English version of Nottingham Extended Activities Of Daily Living Scale will be translated into Urdu and it will be culturally adapted. Nottingham Extended Activities Of Daily Living Scale will be given to eighty individuals of stroke population which were selected on the basis of convenience sampling and the criteria of inclusion and exclusion. Study will investigate both inter-observer and intra-observer reliability of Nottingham Extended Activities Of Daily Living Scale, Modified Barthel Index and Frenchay Activities Index; the 2 set of questionnaire designed will be given to the participants on the same day to be filled, by two observers. And with a gap of half an hour between distributions of first two forms questionnaires will be given for inter-observer assessment. And after a time period of one week a third assessment will be collected by the first observer (intra-observer assessment). Statistical Package of Social Sciences Version 24 will be used for data entry and analysis. Cronbach alpha value will be used for checking internal consistency and intra-class correlation coefficient will be used to analyze test retest reliability.

Study Type

Observational

Enrollment (Actual)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Faisalabad, Punjab, Pakistan, 38000
        • Ripah International University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

67 years and older (Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Stroke population of Pakistan over 67 years of age

Description

Inclusion Criteria:

  1. Having age of 67 years or more
  2. Having stroke
  3. Both males and females

Exclusion Criteria:

  1. Neurological condition other than stroke
  2. Any fracture of lower extremity
  3. Any amputation of lower extremity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nottingham Extended Activities Of Daily Living Scale
Time Frame: 1st day
The purpose of development of Nottingham Extended Activities Of Daily Living Scale was to use it for stroke patients. Each question on the scale is graded either 0 which means patient cannot perform task, 1 which means that patient can do activity but with assistance, 2 which states that task can be performed but with difficulty, 3 which means that he or she can perform the activity on his or her own easily. The score ranges from 0-66.
1st day
Frenchay Activities Index
Time Frame: 1st day
The Frenchay Activities Index is a tool for assessing instrumental activities of daily living in stroke patients. It is based upon the frequency in which activities are performed. Frenchay Activities Index scores vary from 0 (inactive) to 45 (very active), with 0-15 indicating inactivity, 16-30 indicating moderate activity, and 31-45 indicating extreme activity. A score of 18 or more than 18 was used to predict minor impairment following a stroke.
1st day
Modified Barthel Index
Time Frame: 1st day
The Barthel modified index scale is used to assess behavior related to daily tasks in stroke patients or those with other debilitating conditions. Each activity is given a score ranging from 0 (unable to complete task) to 5, 10, or 15 (highest) (fully independent- exact score depends on the activity being evaluated). Summing the scores for each of the items yields a total score.
1st day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Muhammad Kashif, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 30, 2021

Primary Completion (Actual)

July 10, 2023

Study Completion (Actual)

July 12, 2023

Study Registration Dates

First Submitted

June 6, 2022

First Submitted That Met QC Criteria

June 6, 2022

First Posted (Actual)

June 8, 2022

Study Record Updates

Last Update Posted (Actual)

May 7, 2024

Last Update Submitted That Met QC Criteria

May 6, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

3
Subscribe